HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Wants Answers From US FDA On China And India Inspection Plans

Executive Summary

House Republicans keep pressure on US FDA for plans to catch up on inspections after long COVID-19 hiatus. Recent cancer drug shortages could be a headline event to lead into larger probe.

You may also be interested in...



US FDA Finds Poor Data Integrity At Second Intas Plant

After machines counted particles in vials, workers revised reports so out-of-specification batches could be exported to the US and the EU.

House Republicans: Drug Shortage Solutions Must Move Beyond FDA

Energy and Commerce Republicans held off Democrats’ efforts to add drug shortage legislation back into the subcommittee-cleared pandemic preparedness bill 13 July. FDA-focused solutions have failed, GOP members said.

Litigation Follows OTC Eye Drops Recall Due To Bacteria Strain Not Previously Seen In US

Following a recall earlier in February of EzriCare’s and Delsam’s OTC artificial tears due to potential bacterial contamination, plaintiffs’ bar steps in with first of what may be multiple lawsuits. CDC says drug-resistant strain of Pseudomonas aeruginosa bacteria not previously seen in US.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel